课题基金 / 基金详情

Precise point-of-care testing devices for diagnosis and prognosis of ovarian cancer

Precise point-of-care testing devices for diagnosis and prognosis of ovarian cancer
用于卵巢癌诊断和预后的精确即时检测设备
批准号：
451664
负责人：
Thompson Michael
金额：
$23.13万
依托单位：
University of Toronto
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-09-01 至 2024-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=451664&lang=en
关键词：
Cancer Diagnostic Device Cancer Prognostic Device Electrochemical Biosensor Ovarian Cancer Point-Of-Care Testing Device

项目摘要

项目成果

Thompson Michael的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ovarian cancer (OC) is often referred to as the "silent" killer since early-stage symptoms are not radically different from certain normal conditions. Worldwide there are 150,000 deaths, annually, and there are estimated to be more than half of a million
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Surface-oriented antibody capture of endothelial progenitor cells for the reduction of post-stent restenosis
  • 批准号：
    248260
  • 项目类别：
    Operating Grants
  • 资助金额：
    $14.84万
  • 财政年份：
    2011
  • 负责人：
    Thompson Michael
  • 依托单位：
    University of Toronto
海外基金